Written and medically reviewed by Kwaku Osafo-Mensah, MD
Pulmonary Medicine | Sleep Medicine | Diplomate, American Board of Sleep Medicine (ABSM)
Medically reviewed: September 2026.

What Is Inspire for Sleep Apnea?

Inspire for sleep apnea is an implanted treatment for selected people with obstructive sleep apnea who meet appropriate candidacy criteria.

The therapy is a form of hypoglossal nerve stimulation, often abbreviated:

HGNS

or:

HNS

Rather than using a mask to push pressurized air into the upper airway, the system stimulates a nerve that controls important tongue muscles.

The objective is to improve upper-airway stability during sleep.

In simplified terms:

breathing begins → device detects the breathing pattern → stimulation activates selected tongue muscles → the tongue moves or stiffens in a way that helps maintain airway patency

But that simplified description leaves out several important details.

Inspire is:

• Surgically implanted
• Activated and programmed after implantation
• Used during sleep
• Adjustable
• Intended for appropriately selected OSA patients
• Different from CPAP
• Different from an oral appliance
• Not a treatment for every type of sleep apnea

What Is Hypoglossal Nerve Stimulation?

The hypoglossal nerve, also called cranial nerve XII, provides motor innervation to muscles that control tongue movement.

Certain tongue muscles influence upper-airway anatomy.

During obstructive sleep apnea, reduced upper-airway muscle tone and other anatomic and physiologic factors can allow the airway to narrow or collapse during sleep.

Hypoglossal nerve stimulation attempts to improve airway stability by electrically activating selected motor pathways during sleep.

The therapy is therefore sometimes described as:

upper-airway stimulation

or:

hypoglossal nerve stimulation.

Is Inspire the Same as Hypoglossal Nerve Stimulation?

Inspire is a specific commercial hypoglossal nerve stimulation system.

The broader treatment category is hypoglossal nerve stimulation or upper-airway stimulation.

This distinction matters.

Just as:

CPAP describes a treatment modality rather than one particular machine brand.

HGNS describes a therapeutic approach rather than automatically referring to every possible implanted system as Inspire.

Because patients commonly search for “Inspire for sleep apnea,” we will use that familiar term while distinguishing the brand from the broader treatment category.

What Problem Is Inspire Trying to Fix?

In obstructive sleep apnea, the upper airway repeatedly becomes narrowed or blocked during sleep.

Airflow may decrease substantially or stop even though the person continues trying to breathe.

Potential consequences include:

• Repeated apneas and hypopneas
• Oxygen desaturation
• Arousals from sleep
• Sleep fragmentation
• Snoring
• Daytime sleepiness
• Other physiologic stress

Hypoglossal nerve stimulation attempts to reduce obstructive events by improving upper-airway muscle activity during sleep.

For a broader overview of OSA symptoms, diagnosis, testing, and treatment options, see Sleep Apnea: Symptoms, Testing, Treatment & What You Need to Know.

Does Inspire Blow Air Into Your Throat?

No.

This is one of the fundamental differences between Inspire and PAP therapy.

PAP

Provides positive pressure through a mask to help prevent the airway from collapsing.

Hypoglossal Nerve Stimulation

Uses electrical stimulation of selected nerve fibers to activate upper-airway muscles.

Conceptually:

PAP → pneumatic airway stabilization

versus:

HGNS → neuromuscular airway stabilization

For a detailed explanation of how PAP mechanically stabilizes the airway during sleep, see What Your CPAP Machine Actually Does While You Sleep.

Does Inspire Shock Your Tongue?

The word shock is misleading.

The implanted system delivers controlled electrical stimulation to the hypoglossal nerve.

Patients may perceive stimulation as:

• Tongue movement
• A pulling sensation
• Tingling
• Muscle activation
• Another localized sensation

The therapy is programmed to provide stimulation within a clinically appropriate and tolerable range.

It is not intended to deliver a painful electrical shock.

Does the Tongue Move Forward?

Stimulation can produce forward movement and/or stiffening of tongue-related upper-airway structures, depending on which nerve fibers and muscles are activated.

The goal is not:

“Push the tongue as far forward as possible.”

The goal is:

produce an effective pattern of upper-airway opening at a tolerable stimulation level.

More stimulation is not automatically better.

Why Can Tongue Position Affect Sleep Apnea?

The tongue is an important component of the upper airway.

During sleep, reduced neuromuscular tone can contribute to airway narrowing in susceptible individuals.

But OSA is not simply:

“the tongue falls backward.”

Other structures can contribute, including:

• Soft palate
• Lateral pharyngeal walls
• Tonsillar tissue
• Epiglottic region
• Craniofacial anatomy
• Other upper-airway structures

This becomes very important when deciding who is likely to respond to hypoglossal nerve stimulation.

What Parts of the Inspire System Are Implanted?

The system includes implanted components that perform several functions.

Conceptually, these include:

Stimulation Component

A stimulation lead interfaces with the hypoglossal nerve.

Breathing-Sensing Component

The system monitors respiratory activity so stimulation can be coordinated with breathing.

Implantable Pulse Generator

The implanted generator powers and coordinates the therapy.

The exact system design and surgical technique depend on the device and current clinical practice.

Where Is the Inspire Generator Located?

The pulse generator is generally implanted beneath the skin in the upper chest region.

Other components connect the generator with the stimulation and respiratory-sensing systems.

Patients may be able to feel the generator beneath the skin.

The exact appearance varies according to:

• Body habitus
• Surgical placement
• Healing
• Individual anatomy

Is There a Wire in the Neck?

The stimulation lead is surgically positioned in relation to the hypoglossal nerve.

The goal is to activate nerve branches that produce a favorable upper-airway response.

This is why implantation requires specialized surgical expertise.

The therapy is not simply:

“put an electrode somewhere near the tongue.”

Selective nerve activation matters.

How Does Inspire Know When You Are Breathing?

The implanted system uses respiratory sensing to identify the breathing cycle.

This allows stimulation to be coordinated with inspiration.

In simplified terms:

breathing signal detected → stimulation timed to the appropriate portion of respiration → upper-airway muscles activated

This synchronization distinguishes the system from continuous random stimulation.

Does Inspire Stimulate the Tongue Continuously All Night?

Not in the sense of delivering identical uninterrupted stimulation regardless of breathing.

Therapy is coordinated with the respiratory cycle.

The stimulation pattern is programmed according to the system and individual patient.

Does Inspire Work Automatically When You Fall Asleep?

The patient generally controls when therapy is turned on using a remote or compatible controller.

There is usually a programmed delay before stimulation begins.

That allows time to fall asleep before active stimulation starts.

The exact controls and timing depend on the device and programming.

Why Is There a Start Delay?

Imagine turning therapy on and immediately experiencing repeated tongue stimulation while trying to fall asleep.

That could make sleep initiation difficult.

A start delay allows the patient to:

turn therapy on → settle into bed → fall asleep → stimulation begins later

The delay can be individualized within the available programming options.

What if You Are Still Awake When Stimulation Starts?

The patient may notice tongue movement or stimulation while awake.

Depending on the system and programming, the patient may have options such as pausing therapy or allowing another delay before stimulation resumes.

The specific remote functions depend on the device.

What Happens if You Wake Up During the Night?

If stimulation is uncomfortable while awake, the patient may be able to pause therapy temporarily using the controller.

After the programmed pause, therapy can resume.

The objective is to balance:

treatment coverage throughout sleep

with:

patient comfort during awakenings.

Can You Turn Inspire Off?

Yes.

The patient controls therapy activation rather than having the device deliver treatment continuously 24 hours a day.

It is generally intended for use during sleep.

Does Inspire Work During Naps?

Potentially, if therapy is activated for the nap.

Like PAP and an oral appliance, HGNS provides its intended OSA treatment while the therapy is being used.

A device implanted in the body but left turned off during sleep does not provide the intended stimulation treatment during that period.

Does Inspire Cure Sleep Apnea?

It is better described as a treatment rather than an automatic cure.

When effective, HGNS may substantially reduce OSA severity.

Some patients achieve very low residual AHI.

Others improve substantially but retain residual OSA.

Therefore:

implantation ≠ cure

and:

using Inspire ≠ proof that OSA has completely normalized.

Objective treatment assessment remains important.

Does Inspire Remove the Cause of OSA?

Not necessarily.

OSA is often multifactorial.

Potential contributors include:

• Upper-airway anatomy
• Neuromuscular control
• Obesity
• Craniofacial structure
• Sleep stage
• Sleeping position
• Age
• Other physiologic factors

HGNS addresses an important neuromuscular/anatomic component of upper-airway collapse.

It does not erase every OSA risk factor.

Can Inspire Work if Obesity Contributes to OSA?

Potentially, in appropriately selected patients.

But body weight can influence:

• OSA severity
• Upper-airway anatomy
• Treatment response
• Candidacy considerations

Specific BMI criteria can differ between regulatory labeling, clinical practice, Medicare, and commercial insurers.

For a detailed discussion of obesity, weight reduction, GLP-1–based medications, tirzepatide, bariatric surgery, and OSA, see Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

Inspire vs. Oral Appliance: How Are They Different?

Both treatments attempt to improve upper-airway stability without delivering PAP through a mask.

But they work differently.

Oral Appliance

Mechanically advances or stabilizes the lower jaw during sleep.

Hypoglossal Nerve Stimulation

Electrically activates selected upper-airway motor pathways during sleep.

An oral appliance is removable and non-surgical.

HGNS requires surgical implantation.

For a detailed guide to mandibular advancement therapy, see Oral Appliance Therapy for Sleep Apnea: How It Works, Who Qualifies, and Does It Work?

Is Inspire Like a Pacemaker for the Tongue?

You may hear HGNS described casually as:

“a pacemaker for the tongue.”

The analogy can help patients understand that it is an implanted electrical stimulation system.

But it is not technically the same as a cardiac pacemaker.

A cardiac pacemaker manages cardiac electrical activity.

HGNS:

• Senses respiration
• Stimulates selected hypoglossal motor pathways
• Attempts to improve upper-airway patency during sleep

So the phrase is useful only as a rough analogy.

Is Inspire Brain Surgery?

No.

The system does not require implantation into the brain.

The therapy interfaces with a peripheral cranial nerve involved in tongue movement.

Does Inspire Require Surgery?

Yes.

This is a major difference from PAP and oral appliance therapy.

Implantation requires a surgical procedure.

That means candidacy involves consideration of:

• Potential benefit
• Surgical risks
• Anatomy
• OSA characteristics
• Previous treatment experience
• Long-term device management

The decision should not be made simply because someone dislikes wearing a CPAP mask.

Is Inspire an Experimental Treatment?

Hypoglossal nerve stimulation is an established treatment option for appropriately selected patients with obstructive sleep apnea.

It has been studied in prospective clinical trials and long-term follow-up cohorts and has regulatory approval for defined patient populations.

But:

established treatment ≠ appropriate for everyone.

Patient selection is central to its success.

Why Is Patient Selection So Important?

Because HGNS works best when the patient’s pattern of airway collapse and sleep apnea characteristics are compatible with the therapy.

Two patients may have:

the same AHI

but:

• Different airway anatomy
• Different proportions of central events
• Different collapse patterns
• Different body habitus
• Different treatment histories

One may be an excellent candidate.

The other may not be.

Does AHI Alone Determine Inspire Eligibility?

No.

AHI is important, but candidacy involves much more.

Potential considerations include:

• OSA severity
• Obstructive versus central events
• PAP experience
• Upper-airway anatomy
• DISE findings
• Body habitus
• Age
• Other medical considerations
• Device-specific labeling
• Payer requirements

For more about AHI severity, limitations, REM AHI, positional AHI, and interpretation, see AHI Explained: What Your Apnea-Hypopnea Index Means.

Can Inspire Treat Central Sleep Apnea?

Hypoglossal nerve stimulation is designed to address obstructive upper-airway collapse.

Central sleep apnea is fundamentally different.

During central apnea, respiratory effort itself stops or substantially decreases.

Stimulating tongue-related upper-airway muscles does not correct the underlying absence of respiratory drive.

Therefore:

HGNS should not be considered a general treatment for central sleep apnea.

For a detailed comparison of obstructive and central respiratory events, see Central vs. Obstructive Sleep Apnea: What’s the Difference?

What if You Have Both Obstructive and Central Events?

The relative proportions matter.

A small number of central events on a sleep study is different from having a substantial central or mixed apnea burden.

This is one reason candidacy requires review of the actual diagnostic sleep study rather than simply reading:

“AHI = 32.”

The event composition matters.

Is Inspire Mainly for People Who Cannot Use CPAP?

PAP intolerance or inability to obtain adequate benefit from PAP is an important component of HGNS candidacy in many clinical and coverage frameworks.

But the exact definition of PAP failure or intolerance can vary.

Before concluding:

“CPAP didn’t work, therefore I qualify for Inspire,”

it is important to determine why PAP was unsuccessful.

Potentially correctable problems include:

• Poor mask fit
• Excessive leak
• Pressure intolerance
• Nasal obstruction
• Dryness
• Aerophagia
• Ramp problems
• Inadequate troubleshooting
• Incomplete usage

Before concluding that PAP has failed, see CPAP Not Working? Signs Your Sleep Apnea Treatment Needs Reassessment.

If You Hate CPAP, Does That Mean You Qualify?

No.

Disliking PAP may be relevant, but HGNS candidacy requires more than preference.

The evaluation asks whether the patient:

has the appropriate disease + has an appropriate airway pattern + meets relevant clinical/device criteria + can reasonably undergo implantation and long-term management.

Is Inspire a First-Line Treatment for Everyone With OSA?

No.

OSA treatment should be individualized.

Options may include:

• PAP
• Oral appliance therapy
• Positional therapy
• Weight management
• HGNS
• Other surgical approaches
• Combination treatment

The correct option depends on the patient.

Can You Choose Inspire Simply Because You Don’t Want a Mask?

Patient preference matters, but it does not replace candidacy evaluation.

An implanted therapy carries different considerations from a removable treatment.

Those include:

• Surgery
• Device programming
• Long-term follow-up
• Battery/generator management
• Device-specific precautions
• Potential revision procedures

The decision should reflect those tradeoffs.

Does Inspire Work the First Night After Surgery?

Generally, implantation and therapeutic activation are separate stages.

The tissues need time to heal after surgery.

The system is typically activated later according to the clinical protocol.

Therefore:

implantation day ≠ fully programmed treatment night.

Do You Stop CPAP Immediately After Implant Surgery?

Do not assume so.

Until the implanted system is activated and providing adequate therapy, the patient’s underlying OSA still exists.

Perioperative and postoperative OSA management should follow the treating surgical and sleep teams’ instructions.

Does Inspire Need Adjustment After Activation?

Yes.

The initial stimulation settings may not represent the final therapeutic settings.

Patients typically undergo a period of:

activation → acclimation → adjustment/programming → assessment of response

The objective is to achieve effective stimulation while maintaining comfort.

Is Stronger Stimulation Always Better?

No.

This is analogous to several other OSA therapies.

More is not automatically better.

Excessive stimulation may become uncomfortable or disturb sleep.

Insufficient stimulation may fail to adequately improve airway patency.

The goal is:

effective + tolerable stimulation

rather than:

maximum stimulation.

Can Inspire Wake You Up?

Stimulation that is uncomfortable or poorly timed may contribute to awakenings in some patients.

Programming and acclimation can therefore matter.

The patient should not simply assume:

“If I can feel it strongly, it must be working better.”

Can Inspire Treat Snoring?

Snoring may improve when upper-airway obstruction improves.

But:

less snoring ≠ proof that OSA is fully controlled.

The same principle applies to:

• PAP
• Oral appliances
• Positional therapy
• HGNS

Objective outcomes matter.

Does Inspire Record Your AHI Every Night?

The implanted system’s primary purpose is stimulation therapy, not conventional full sleep-study measurement.

Patients should not assume that the device independently provides the equivalent of a polysomnogram every night.

Treatment efficacy may require clinical assessment and appropriate objective sleep testing.

How Do You Know Whether Inspire Is Actually Working?

Consider several domains:

• AHI or REI
• Oxygenation
• Snoring
• Daytime symptoms
• Treatment usage
• Stimulation tolerance
• Sleep quality
• Residual positional or REM-related OSA

The most important question is not:

“Is the implant turned on?”

It is:

“Does the therapy adequately control the obstructive sleep apnea while the patient uses it?”

The HGNS Principle

Think of Inspire as a treatment pathway, not simply an implanted device.

The pathway is:

confirm appropriate OSA → evaluate PAP experience → assess candidacy → evaluate upper-airway anatomy → implant appropriate patient → allow healing → activate therapy → acclimate and program → objectively assess efficacy → monitor long term

An implanted generator does not guarantee successful OSA treatment.

Successful therapy depends on:

appropriate selection + appropriate implantation + effective programming + consistent use + objective follow-up.

Who Qualifies for Inspire for Sleep Apnea?

Not everyone with obstructive sleep apnea is a candidate for hypoglossal nerve stimulation.

Candidacy generally requires evaluation of several separate questions:

• Does the patient have obstructive sleep apnea?
• How severe is the OSA?
• How much of the respiratory-event burden is obstructive versus central or mixed?
• Has PAP been appropriately attempted, and what happened?
• Is the upper-airway anatomy compatible with HGNS?
• What does drug-induced sleep endoscopy show?
• Are body weight and other clinical factors compatible with treatment?
• Can the patient undergo surgery and long-term device management?
• Does the patient meet the requirements of the particular device and payer?

The important principle is:

Having OSA and disliking CPAP does not automatically mean you qualify for Inspire.

Why Is Inspire Eligibility So Confusing?

Because the word qualify can mean several different things.

A patient may be asking:

“Is HGNS medically reasonable for me?”

while an insurer may be asking:

“Does this patient meet our coverage criteria?”

and device labeling may define:

“For which population is this system currently indicated?”

Those are related questions, but they are not identical.

FDA Labeling, Clinical Candidacy, and Insurance Coverage Are Not the Same Thing

It is useful to separate four concepts.

1. Regulatory/Device Labeling

This describes the population and circumstances for which a specific device has regulatory authorization or approval.

2. Clinical Candidacy

The treating clinicians determine whether HGNS is medically appropriate for the individual patient.

3. Medicare Coverage

Medicare coverage policies may establish additional requirements for reimbursement.

4. Commercial Insurance Coverage

Private insurers may use their own medical-necessity criteria and authorization processes.

Therefore, a number found online should not automatically be interpreted as:

“the universal Inspire qualification rule.”

Specific criteria should be verified using current device labeling and the patient’s current coverage policy.

Do You Need Obstructive Sleep Apnea to Qualify?

Yes, HGNS is fundamentally an obstructive sleep apnea treatment.

The therapy attempts to improve upper-airway patency through stimulation of selected hypoglossal motor pathways.

That mechanism does not correct absent respiratory drive.

Therefore, determining whether respiratory events are:

• Obstructive
• Central
• Mixed

is an important part of candidacy.

For a detailed comparison of obstructive and central respiratory events, see Central vs. Obstructive Sleep Apnea: What’s the Difference?

Does Inspire Treat Central Sleep Apnea?

HGNS should not be considered a general treatment for central sleep apnea.

During an obstructive apnea:

respiratory effort continues while the upper airway is blocked.

During a central apnea:

respiratory effort itself stops or substantially decreases.

Stimulating upper-airway muscles does not correct the underlying absence of respiratory drive.

What if Your Sleep Study Shows Some Central Apneas?

A small number of central events does not necessarily mean the patient has central sleep apnea as the dominant disorder.

The important questions include:

• How many central events occurred?
• How many mixed events occurred?
• What proportion of the total event burden is central or mixed?
• Were the events clinically significant?
• What was the testing context?

HGNS candidacy frameworks commonly place limits on the proportion of central and mixed respiratory events.

The exact criterion should be verified against the current device and payer requirements.

Why Does the Percentage of Central Events Matter?

Consider two simplified patients.

Patient A

AHI: 30

Almost all events are obstructive.

Patient B

AHI: 30

A substantial proportion of events are central.

The AHI is identical.

The underlying physiology is not.

Patient A may have a disease mechanism compatible with HGNS.

Patient B may require a very different treatment strategy.

This is why:

AHI alone does not determine Inspire candidacy.

What AHI Do You Need for Inspire?

HGNS is generally considered for patients with clinically significant obstructive sleep apnea within the range allowed by the particular device labeling and clinical/coverage framework.

But readers should be cautious with exact numbers found online.

AHI eligibility ranges have evolved as indications and evidence have expanded.

In addition, an insurer may apply a coverage range that differs from broader device labeling.

Therefore:

current device indication + current payer criteria + individual clinical assessment

should determine whether a particular AHI is eligible.

Is Inspire Only for Moderate-to-Severe OSA?

HGNS has primarily been developed and studied for clinically significant obstructive sleep apnea rather than routine treatment of uncomplicated mild OSA.

A patient with mild OSA often has several less invasive treatment options available.

For more about treatment decisions when OSA falls within the mild range, see Mild Sleep Apnea: Does It Need Treatment?

Does Severe OSA Automatically Make You a Candidate?

No.

A high AHI does not establish candidacy.

A patient may still have:

• Excessive central/mixed events
• Incompatible airway-collapse anatomy
• Other surgical considerations
• Coverage limitations
• Another reason HGNS is inappropriate

Conversely, an appropriately selected patient with substantial OSA may respond well.

Why Should the Diagnostic Sleep Study Be Reviewed?

Because the report contains information beyond the headline AHI.

Relevant findings may include:

• Obstructive apnea burden
• Central apnea burden
• Mixed events
• Oxygen desaturation
• REM-related severity
• Positional severity
• Study quality
• Total sleep or monitoring time

For more about AHI severity, limitations, REM AHI, positional AHI, and interpretation, see AHI Explained: What Your Apnea-Hypopnea Index Means.

Do You Have to Try CPAP Before Inspire?

PAP experience is an important part of HGNS candidacy in current clinical and coverage frameworks.

HGNS is commonly considered when PAP has not provided a sustainable treatment solution because of documented failure or intolerance.

But the exact definition of:

PAP failure

and:

PAP intolerance

can differ according to the device, clinical program, and payer.

What Does PAP Failure Mean?

The term should be used carefully.

It can refer to circumstances in which PAP does not adequately control the patient’s OSA despite appropriate management.

But before declaring PAP ineffective, consider:

• Mask leak
• Pressure settings
• PAP mode
• Treatment usage
• Residual obstructive events
• Central events
• Nasal obstruction
• Other technical or clinical problems

A correctable PAP problem should not automatically be labeled permanent treatment failure.

What Does PAP Intolerance Mean?

PAP intolerance generally refers to inability to use PAP adequately despite reasonable attempts at treatment.

Potential problems may include:

• Persistent mask intolerance
• Claustrophobia
• Pressure intolerance
• Aerophagia
• Repeated unconscious mask removal
• Severe dryness
• Sleep disruption
• Other persistent barriers

But an insurer may require specific documentation of PAP usage, attempted treatment, or intolerance.

For a broader framework for determining why PAP treatment is unsuccessful, see CPAP Not Working? Signs Your Sleep Apnea Treatment Needs Reassessment.

Does One Bad Night With CPAP Count as Intolerance?

No.

PAP adaptation can take time.

Many early problems are correctable through:

• Mask refitting
• Leak management
• Humidification
• Pressure review
• Ramp adjustment
• Nasal treatment
• Education
• Acclimation

HGNS should not be viewed simply as a shortcut around routine PAP troubleshooting.

What if CPAP Controls the OSA but You Cannot Keep It On?

That may be clinically relevant.

For example:

CPAP-treated AHI: 2

but:

PAP use: 1–2 hours per night

while the patient sleeps substantially longer.

The issue is not physiologic PAP efficacy.

The problem is inadequate treatment exposure.

That distinction may matter when documenting PAP intolerance and discussing alternative treatment.

For more about why insurance compliance thresholds and full-night physiologic treatment coverage are not the same thing, see CPAP Compliance: How Many Hours a Night Should You Use CPAP?

Is There a BMI Limit for Inspire?

Body mass index is an important consideration, but this is an area where online information frequently becomes misleading.

You may encounter different BMI numbers because:

• Device labeling has evolved
• Clinical programs may use selection thresholds
• Medicare may have coverage requirements
• Commercial insurers may apply different criteria
• Evidence about treatment response across BMI ranges continues to develop

Therefore, there is no single BMI number that should be presented here as the universal answer for every patient.

Why Does BMI Matter?

Higher body weight can influence:

• Upper-airway soft tissue
• Tongue and regional adiposity
• Pharyngeal collapsibility
• OSA severity
• Surgical considerations
• Treatment response

Population-level data suggest that body habitus can influence the probability of HGNS response.

But:

BMI does not tell us everything about an individual’s airway.

Does a Higher BMI Automatically Mean Inspire Will Not Work?

No.

Response exists on a continuum.

But candidacy and probability of treatment success may change as obesity becomes more substantial.

This is why clinicians should distinguish:

technically allowed

from:

likely to provide an optimal response.

Those are not necessarily the same thing.

Can Weight Loss Change Inspire Candidacy?

Potentially.

Weight reduction may:

• Reduce OSA severity
• Change upper-airway physiology
• Alter treatment options
• Affect candidacy under certain clinical or coverage criteria

For some patients, weight management may therefore be an important part of the treatment strategy whether or not HGNS is ultimately selected.

See Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

What if You Lose Weight After Inspire Implantation?

OSA severity and treatment requirements can change after substantial weight loss.

That does not mean the implant should automatically be stopped.

The patient’s response can be reassessed based on:

• Symptoms
• Device use
• Stimulation requirements
• Objective sleep testing when appropriate

Similarly, substantial weight gain may affect treatment response.

Does Age Matter for Inspire?

Yes, but again, exact eligibility depends on the particular device labeling and patient population.

Age matters because:

• Regulatory indications are age-specific
• Pediatric and adult OSA differ
• Anatomy and underlying causes differ
• Surgical considerations differ

This article focuses primarily on adult obstructive sleep apnea unless otherwise stated.

Can Children Receive Hypoglossal Nerve Stimulation?

HGNS has been studied and used in selected pediatric populations, particularly in specific clinical circumstances.

However, pediatric candidacy should not be extrapolated from adult criteria.

Children with OSA require age-appropriate evaluation and treatment.

Why Does Upper-Airway Anatomy Matter?

HGNS works by activating upper-airway muscles.

If the patient’s airway collapses in a pattern that does not respond favorably to that stimulation, treatment may be less effective.

Therefore, candidacy requires more than:

Sleep study + BMI + CPAP intolerance.

The airway itself must be evaluated.

What Is DISE?

DISE stands for:

Drug-Induced Sleep Endoscopy.

It is a procedure used to examine the upper airway while the patient is sedated in a sleep-like state.

A flexible endoscope allows the clinician to observe how different parts of the upper airway narrow or collapse.

Potential sites include:

• Soft palate
• Oropharyngeal/lateral walls
• Tongue base
• Epiglottic region

DISE can provide information that is not available from AHI alone.

Why Is DISE Used Before Inspire?

Because the pattern of airway collapse matters.

Two patients can have the same AHI but very different obstruction.

For example:

Patient A

Predominant tongue-base-related obstruction with a favorable palatal pattern.

Patient B

A different pattern involving circumferential collapse at the soft palate.

Those patients may not have the same probability of HGNS success.

What Is Complete Concentric Collapse?

One of the most important terms in HGNS candidacy is:

complete concentric collapse of the soft palate

often abbreviated:

CCC

This describes a pattern in which the velum/soft-palate region collapses concentrically rather than primarily in an anterior-posterior direction.

Historically, complete concentric collapse at the velum has been an important unfavorable finding for conventional unilateral hypoglossal nerve stimulation candidacy.

Why Does Complete Concentric Collapse Matter?

The mechanism of conventional HGNS depends on creating a favorable upper-airway response through tongue-related neuromuscular activation.

Certain collapse patterns respond better than others.

Complete concentric palatal collapse has been associated with poorer response to conventional HGNS and is therefore specifically assessed during candidacy evaluation.

This is why DISE is not merely:

“another sleep test.”

It answers a different question:

How does this patient’s airway actually collapse?

Can a Regular Sleep Study Detect Complete Concentric Collapse?

No—not directly.

A polysomnogram can tell us a great deal about:

• Respiratory events
• Oxygenation
• Sleep stages
• Arousals
• Position

But it does not directly visualize the airway during obstruction.

DISE provides dynamic anatomic information.

Is DISE the Same as a Sleep Study?

No.

Sleep Study

Measures physiologic sleep and breathing information.

DISE

Visualizes upper-airway collapse under sedation.

They answer different questions.

A patient may need both during an HGNS evaluation.

Do Large Tonsils Affect Inspire Candidacy?

They can.

Substantial tonsillar enlargement may represent an important anatomic source of upper-airway obstruction.

In some patients, addressing a major surgically correctable obstruction may be more appropriate than proceeding directly to HGNS.

The entire airway should be evaluated rather than focusing only on the tongue.

Does Nasal Obstruction Prevent Inspire From Working?

Not automatically.

HGNS does not require a nasal PAP mask.

But significant nasal obstruction may still affect:

• Sleep quality
• Mouth breathing
• Snoring
• Upper-airway physiology
• Overall treatment experience

Clinically important nasal disease deserves appropriate evaluation.

What Other Medical Factors Matter?

Surgical candidacy involves the whole patient.

Considerations may include:

• Cardiovascular disease
• Pulmonary disease
• Bleeding risk
• Anticoagulant therapy
• Infection risk
• Anesthesia considerations
• Other implanted devices
• Neuromuscular conditions
• Ability to operate the therapy controller
• Ability to participate in follow-up

The specific relevance depends on the individual.

What About Other Implanted Electrical Devices?

Patients with other implanted electronic devices should tell the treating team.

Potential device-device interactions and procedural considerations depend on the specific systems involved.

Compatibility should be verified rather than assumed.

Does Having a Pacemaker Automatically Exclude Inspire?

Not necessarily.

But the specific implanted systems, locations, programming, and potential interactions require evaluation.

The correct question is not:

“Do you have any implant?”

It is:

“Are these particular implanted systems compatible and manageable together?”

What About Pregnancy?

Pregnancy can affect sleep apnea and medical decision-making.

Elective implantation decisions and device-specific considerations should be discussed with the appropriate treating teams.

Do not rely on a general internet statement for an individualized pregnancy-related device decision.

What if You Have Severe Lung Disease?

Significant pulmonary disease can complicate sleep-related breathing abnormalities.

A patient may have:

• OSA
• Nocturnal hypoxemia
• Hypoventilation
• Another respiratory disorder

HGNS treats upper-airway obstruction.

It does not automatically correct every cause of nocturnal hypoxemia or hypoventilation.

For more about interpreting nocturnal desaturation and distinguishing intermittent OSA-related desaturation from sustained hypoxemia, see Sleep Apnea and Oxygen Levels: How Low Is Too Low?

Does Oxygen Desaturation Determine Inspire Candidacy?

Oxygenation is clinically important, but there is no single oxygen number that independently determines candidacy.

The clinician may consider:

• Baseline saturation
• Lowest reliable saturation
• Desaturation pattern
• Event-related oxygen burden
• Pulmonary disease
• OSA severity

The complete clinical picture matters.

Can Inspire Be Used for Positional OSA?

Potentially, but positional phenotype should be understood.

Suppose:

Supine AHI: 40

Nonsupine AHI: 5

That patient has a different treatment opportunity from someone with severe obstruction in every position.

Less invasive positional treatment may be relevant in selected patients.

For more about supine and nonsupine AHI and positional treatment, see Positional Sleep Apnea: Why Sleeping on Your Back Can Make OSA Worse.

What About REM-Related OSA?

REM-related severity can also matter.

A patient may have:

Overall AHI: 18

but:

REM AHI: 42

The overall number alone may obscure substantial disease during REM.

Candidacy and follow-up should consider the entire sleep-study pattern rather than only the headline AHI.

For more about REM-predominant obstruction, see REM-Related Sleep Apnea: What Does REM AHI Mean?

Can an Oral Appliance Be Tried Before Inspire?

Potentially.

For some patients, oral appliance therapy may provide an effective non-surgical alternative.

Whether it is appropriate depends on:

• OSA severity
• Dental anatomy
• Jaw function
• Patient preference
• Expected response
• Previous treatment

For a detailed guide to mandibular advancement therapy, see Oral Appliance Therapy for Sleep Apnea: How It Works, Who Qualifies, and Does It Work?

Do You Have to Fail an Oral Appliance Before Inspire?

Not universally.

Coverage and clinical pathways differ.

Do not assume that every patient must progress through:

CPAP → oral appliance → Inspire

in a rigid sequence.

Treatment selection should reflect the actual clinical and coverage requirements.

What Happens During an Inspire Candidacy Evaluation?

A typical evaluation may involve several components:

1. Review the OSA Diagnosis

Confirm the diagnosis and severity.

2. Review the Sleep Study

Assess obstructive, central and mixed events, oxygenation, position, and other relevant findings.

3. Review PAP Experience

Determine whether PAP failure or intolerance has been adequately documented and whether correctable problems have been addressed.

4. Assess Body Weight and Medical Factors

Consider obesity, surgical risk, comorbidities, and relevant eligibility requirements.

5. Examine the Upper Airway

Identify major anatomic contributors.

6. Perform DISE When Required/Appropriate

Determine the dynamic pattern of airway collapse.

7. Review Device and Insurance Criteria

Confirm current labeling and coverage requirements.

8. Discuss Alternatives

Consider PAP optimization, oral appliance therapy, positional therapy, weight management, other surgery, and combination approaches when appropriate.

9. Discuss Surgery and Long-Term Management

The patient should understand that implantation is only the beginning of treatment.

Ten Questions to Ask During an Inspire Evaluation

1. What type of sleep apnea do I have?

Confirm that the disease is predominantly obstructive.

2. What is my current AHI?

Know the actual severity and when the study was performed.

3. How Many of My Events Are Central or Mixed?

Ask for more than the total AHI.

The proportion of obstructive, central, and mixed respiratory events matters because HGNS is designed primarily to treat obstructive upper-airway collapse.

4. Why Was PAP Unsuccessful for Me?

Determine whether the problem involved:

• Mask intolerance
• Leak
• Pressure
• Aerophagia
• Nasal obstruction
• Repeated mask removal
• Inadequate usage
• Persistent respiratory events
• Another problem

Correctable PAP problems deserve attention before concluding that PAP cannot provide effective treatment.

5. Does My Body Weight Affect My Candidacy?

Ask how your current body weight relates to:

• Expected treatment response
• Device labeling
• The clinical program’s selection criteria
• Insurance coverage requirements

Do not rely on a BMI cutoff found on an old website or social-media post.

6. Do I Need Drug-Induced Sleep Endoscopy?

Ask why DISE is being performed and what airway-collapse pattern the clinician is looking for.

In particular, ask whether there is evidence of:

complete concentric collapse at the soft palate.

7. What Does My Airway Anatomy Show?

Ask whether obstruction appears to involve:

• Soft palate
• Lateral pharyngeal walls
• Tongue base
• Tonsils
• Epiglottic region
• Multiple levels

HGNS candidacy is an anatomic as well as physiologic decision.

8. What Improvement Should I Realistically Expect?

Do not ask only:

“Will Inspire cure my sleep apnea?”

Ask:

• What degree of AHI reduction is realistic?
• How often does OSA normalize?
• What happens to oxygenation?
• What happens to symptoms?
• What would count as inadequate response?

9. What Happens if Inspire Only Partially Works?

Before surgery, understand the possible next steps.

These might include:

• Further programming
• Positional therapy
• Weight management
• PAP
• Oral appliance therapy
• Combination treatment
• Additional evaluation

Implantation should not create the expectation that no other OSA treatment will ever be needed.

10. What Will Long-Term Follow-Up Involve?

Ask about:

• Surgical follow-up
• Activation
• Programming
• Acclimation
• Objective sleep testing
• Device checks
• Battery/generator management
• MRI considerations
• What happens if symptoms return

HGNS is a long-term treatment relationship, not a one-time surgical procedure.

Who Is Most Likely to Benefit From Inspire?

There is no perfect bedside formula.

However, successful HGNS treatment generally depends on alignment among several factors:

predominantly obstructive disease + appropriate OSA severity + compatible airway anatomy + acceptable surgical candidacy + appropriate PAP history + favorable stimulation response + consistent use

No single factor guarantees success.

Can DISE Predict Exactly How Well Inspire Will Work?

No.

DISE provides important information about airway-collapse pattern and helps identify anatomy that may be unfavorable for conventional HGNS.

But it cannot guarantee an individual’s final AHI.

Think of DISE as:

an important selection tool

rather than:

a perfect response predictor.

Can Someone Pass All the Qualification Criteria and Still Not Respond Well?

Yes.

Meeting candidacy criteria increases the likelihood that the therapy is being used in an appropriate population.

It does not guarantee:

• Complete normalization of AHI
• Elimination of oxygen desaturation
• Resolution of all symptoms
• Perfect stimulation tolerance

Individual response still varies.

Can Someone Outside a Common Insurance Criterion Still Be Medically Considered?

Potentially, depending on the specific circumstance, device labeling, evidence, clinical judgment, and applicable regulatory requirements.

But:

medical consideration ≠ insurance coverage.

A payer may decline coverage even when a clinician believes a treatment deserves consideration.

Likewise, insurance authorization does not guarantee treatment success.

Why Should Current Criteria Be Verified?

Because HGNS has evolved.

Over time there may be changes in:

• Device indications
• Age ranges
• AHI ranges
• BMI-related labeling
• Clinical evidence
• Medicare policies
• Commercial insurance policies

For that reason, this article deliberately avoids presenting an old eligibility table as a permanent universal rule.

Patients undergoing evaluation should have their candidacy checked against current criteria at the time of treatment.

The Inspire Candidacy Principle

Do not reduce HGNS eligibility to:

“AHI + BMI + CPAP intolerance = Inspire.”

A more accurate framework is:

Confirm predominantly obstructive OSA

↓

Review severity and complete sleep-study findings

↓

Understand why PAP has not provided sustainable treatment

↓

Evaluate body weight, medical factors, and surgical candidacy

↓

Evaluate upper-airway anatomy

↓

Assess dynamic collapse with DISE when appropriate

↓

Confirm current device and payer requirements

↓

Discuss alternatives and realistic expectations

↓

Proceed only when the overall risk-benefit profile makes sense

The question is therefore not merely:

“Do I qualify for Inspire?”

It is:

“Am I an appropriate candidate for hypoglossal nerve stimulation, how likely is it to adequately control my OSA, and how does it compare with my other reasonable treatment options?”

How Effective Is Inspire for Sleep Apnea?

Hypoglossal nerve stimulation can substantially improve obstructive sleep apnea in appropriately selected patients.

Clinical studies have demonstrated improvements in outcomes such as:

• AHI
• Oxygen desaturation measures
• Snoring
• Daytime sleepiness
• Sleep-related quality of life

Long-term follow-up studies have also shown that benefit can persist for years in many patients who respond to therapy.

But the most important word is:

selected.

HGNS outcomes from carefully selected clinical-trial populations should not be interpreted as proof that every person with OSA will achieve the same response.

Does Inspire Cure Sleep Apnea?

Not necessarily.

Some patients achieve very low residual AHI values.

Others experience substantial improvement while still having residual OSA.

Others respond less strongly.

Therefore:

successful implantation ≠ guaranteed cure

and:

treatment response ≠ complete normalization in every patient.

The goal is adequate control of clinically important OSA, not simply having an implanted device.

How Much Can Inspire Lower AHI?

The degree of improvement varies substantially among individuals.

Consider three simplified examples.

Patient A

Before HGNS:

AHI: 32

After optimized therapy:

AHI: 4

This represents excellent objective control.

Patient B

Before HGNS:

AHI: 32

After therapy:

AHI: 13

This represents substantial improvement, but clinically relevant residual OSA remains.

Patient C

Before HGNS:

AHI: 32

After therapy:

AHI: 25

This represents a much more limited response.

All three patients can have a functioning implant.

The difference is the physiologic response to treatment.

What Does “Treatment Responder” Mean?

This term requires careful interpretation.

Clinical trials may define a treatment responder using a combination of:

• Percentage reduction in AHI
• Final AHI threshold
• Other predefined criteria

A commonly used research framework in HGNS studies has involved a substantial percentage reduction in AHI combined with a final AHI below a specified threshold.

But:

research responder ≠ necessarily normal sleep breathing.

For example, a patient can meet a study’s responder definition and still have residual OSA.

Why Does the Definition of Success Matter?

Consider:

AHI 40 → AHI 18

That is a large reduction.

But moderate residual OSA remains.

Now consider:

AHI 20 → AHI 3

The absolute reduction is smaller, but the final result represents much more complete control.

Therefore, treatment should be evaluated using both:

degree of improvement

and:

remaining disease burden.

Should the Goal Be an AHI Below 5?

An AHI below 5 events/hour on an appropriate treatment assessment may represent excellent control according to conventional adult thresholds.

But the complete result still matters.

Consider:

• Oxygenation
• Symptoms
• Sleep stage
• Body position
• Study quality
• Comorbidities
• Treatment usage

See AHI Explained: What Your Apnea-Hypopnea Index Means.

What Did the Major Inspire Studies Show?

One of the pivotal studies of upper-airway stimulation was the STAR trial.

STAR evaluated selected patients with moderate-to-severe obstructive sleep apnea who had difficulty with CPAP and met specific clinical and anatomic selection criteria.

The study demonstrated substantial reductions in measures of obstructive sleep apnea after upper-airway stimulation.

Longer-term follow-up subsequently demonstrated persistent benefit in many participants.

What Was the STAR Trial?

STAR stands for:

Stimulation Therapy for Apnea Reduction.

It was a prospective multicenter study evaluating implanted upper-airway stimulation in carefully selected adults with OSA.

The study helped establish the clinical evidence base for hypoglossal nerve stimulation.

Did AHI Improve in STAR?

Yes.

The pivotal trial demonstrated a substantial reduction in median AHI after treatment.

The original published results showed that median AHI decreased from approximately:

29 events/hour at baseline

to approximately:

9 events/hour at 12 months.

That is a major population-level improvement.

But it should not be translated into:

“Inspire will lower your AHI from 29 to 9.”

Individual responses vary.

Did Oxygen Desaturation Improve?

Yes.

The STAR study also evaluated an oxygen desaturation index, and this improved substantially after treatment.

This is important because OSA is not defined solely by the number of respiratory events.

The oxygen consequences of those events also matter.

See Sleep Apnea and Oxygen Levels: How Low Is Too Low?

Did Everyone in STAR Respond?

No.

This is critical.

Some participants met predefined response criteria.

Others did not.

That is one reason careful patient selection and follow-up remain central to HGNS treatment.

Clinical-trial averages should never be converted into an individual guarantee.

Does Inspire Keep Working Long Term?

Long-term follow-up of patients treated with upper-airway stimulation has demonstrated sustained improvement in many participants over several years.

That is reassuring because HGNS is intended as a long-term therapy rather than a temporary intervention.

But long-term success still depends on factors such as:

• Continued device use
• Appropriate programming
• Body-weight changes
• Changes in OSA physiology
• Device function
• Other health changes

An implant that worked well years ago should still be reassessed if clinically important symptoms return.

Can OSA Become Worse Again After Initially Successful Inspire Treatment?

Potentially.

Possible contributors include:

• Weight gain
• Aging
• Changes in airway anatomy
• Changes in sleeping position
• Device or lead issues
• Changes in stimulation needs
• Other medical conditions

Return of symptoms should not automatically be dismissed because the implant previously worked.

Can Weight Gain Reduce Inspire Effectiveness?

Potentially.

Substantial weight gain may increase:

• Upper-airway soft tissue
• Pharyngeal collapsibility
• OSA severity

That may change the amount of residual disease present despite stimulation.

See Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

Can Weight Loss Improve Results After Inspire?

Potentially.

If obesity contributes significantly to OSA, substantial weight reduction may reduce the underlying burden of upper-airway obstruction.

HGNS and weight management therefore need not be competing treatments.

A patient may appropriately receive:

HGNS → treats upper-airway neuromuscular obstruction during sleep

while:

Weight management → reduces an important underlying disease contributor over time.

Major weight change may justify reassessment of OSA and treatment requirements.

Does Inspire Improve Snoring?

Snoring often improves when upper-airway obstruction improves.

This can be very noticeable to patients and bed partners.

But:

Less snoring does not prove OSA has normalized.

A patient may experience dramatic snoring improvement while still having:

• Residual hypopneas
• REM-related obstruction
• Positional obstruction
• Oxygen desaturation

Snoring is a useful symptom.

It is not a complete treatment metric.

What if My Partner Says I No Longer Stop Breathing?

That is encouraging.

Bed-partner observations can provide useful information about:

• Snoring
• Gasping
• Obvious witnessed apnea
• Restlessness

But a bed partner cannot reliably quantify:

• Hypopneas
• AHI
• Oxygen desaturation
• REM-related events
• Subtle respiratory arousals

Objective assessment remains important.

Does Inspire Improve Daytime Sleepiness?

It can.

Clinical studies have demonstrated improvement in measures of daytime sleepiness among many treated patients.

That makes physiologic sense when OSA-related sleep fragmentation improves.

Potential benefits may include:

• Greater daytime alertness
• Less sleepiness
• Improved concentration
• Better quality of life

But persistent sleepiness does not automatically prove that HGNS has failed.

Why Might You Still Be Tired Even if Inspire Controls the OSA?

Other causes include:

• Insufficient sleep
• Insomnia
• Circadian misalignment
• Medications
• Depression
• Other sleep disorders
• Medical illness

Treating OSA does not guarantee that every cause of fatigue or sleepiness disappears.

What if You Feel Better but the AHI Is Still High?

Both pieces of information matter.

For example:

AHI 38 → 17

plus:

major improvement in daytime sleepiness

represents meaningful benefit.

But moderate residual OSA remains.

The next question is:

Can treatment be further optimized or combined with another strategy?

What if the AHI Is Excellent but You Still Feel Tired?

Then persistent sleepiness deserves evaluation beyond OSA control.

Do not keep increasing stimulation simply because:

“I am still tired.”

If respiratory events are already well controlled, stronger stimulation may not address the true cause of symptoms.

Does Inspire Improve Quality of Life?

Many patients who respond to therapy report improvements in sleep-related quality-of-life measures.

Potential reasons include:

• Reduced sleepiness
• Less snoring
• Fewer breathing disturbances
• Freedom from a PAP mask
• Improved sleep continuity

But quality-of-life improvement remains an individual outcome.

Does Inspire Improve Blood Pressure?

OSA treatment can influence cardiovascular physiology, and research continues to evaluate cardiovascular outcomes with HGNS.

However, HGNS should not be advertised as:

“a treatment that cures hypertension.”

Blood pressure depends on many factors.

These include:

• Genetics
• Obesity
• Kidney disease
• Diet
• Medications
• Physical activity
• Diabetes
• Vascular disease
• OSA

Hypertension should continue to be managed appropriately regardless of the OSA treatment selected.

Does Inspire Prevent Heart Attack or Stroke?

That claim would be too strong.

OSA is associated with cardiovascular and cerebrovascular risk, but demonstrating that a particular OSA therapy prevents individual cardiovascular events requires specific outcome evidence.

HGNS should not be marketed as a guaranteed method of preventing:

• Heart attack
• Stroke
• Atrial fibrillation
• Heart failure

For more about cardiovascular, cerebrovascular, perioperative, and accident risks associated with untreated OSA, see Untreated Sleep Apnea Risks: Heart Disease, Stroke, High Blood Pressure, Surgery, and Accidents.

Is Inspire More Effective Than CPAP?

If the comparison is purely

“Which treatment can most completely eliminate obstructive respiratory events when optimally used?”

PAP remains an extremely effective treatment across a broad range of OSA.

HGNS has a different advantage:

it may provide substantial treatment to appropriately selected patients who cannot achieve sustainable PAP therapy.

Therefore, the comparison is not simply

CPAP AHI versus Inspire AHI.

Real-world treatment also depends on:

• Usage
• Tolerance
• Disease severity
• Treatment response
• Patient selection

Can Inspire Work Better Than CPAP for Someone Who Never Uses CPAP?

This illustrates the difference between efficacy and effectiveness.

Suppose:

CPAP

When worn:

AHI 1

but actual usage:

30 minutes per night

HGNS

When activated:

AHI 6

and therapy is used throughout most sleep periods.

The real-world comparison cannot be reduced to:

1 versus 6.

Treatment exposure matters.

This does not mean HGNS is physiologically superior to PAP.

It means a therapy must actually be used to provide benefit.

How Often Do Patients Use Inspire?

Adherence to HGNS has generally been favorable in published clinical experience.

The therapy avoids several common PAP barriers:

• Mask discomfort
• Mask leak
• Tubing
• Pressurized airflow sensation
• Humidification problems

But HGNS has its own adherence barriers.

These may include:

• Stimulation discomfort
• Difficulty falling asleep with stimulation
• Awakenings
• Forgetting to activate therapy
• Programming problems
• Other device-related issues

Implantation does not guarantee nightly use.

Does Inspire Track Usage?

The system can provide device-related information useful to the treating team, including aspects of therapy use and programming.

The exact information available depends on the system and clinical interface.

Patients should not assume that this is identical to the detailed nightly PAP dashboard produced by every CPAP platform.

Can Inspire Be Used Every Night?

That is generally the intent when the patient sleeps.

Like other OSA therapies:

Treatment works during treatment exposure.

If a patient sleeps without activating therapy, the underlying tendency toward obstructive airway collapse may still be present.

Should Inspire Be Used for the Entire Sleep Period?

Ideally, OSA treatment should cover the sleep period during which clinically significant obstruction occurs.

That includes:

• Early-night sleep
• Late-night sleep
• Naps when relevant

This may be particularly important for patients whose OSA becomes worse during REM sleep, because REM sleep often becomes more prominent later in the sleep period.

See REM-Related Sleep Apnea: What Does REM AHI Mean?

Can Inspire Work Differently on Your Back?

Potentially.

Sleeping position can affect OSA severity even when therapy is being used.

A patient may have excellent control while nonsupine but residual obstruction while sleeping on the back.

For example:

Treated nonsupine AHI: 3

Treated supine AHI: 15

That pattern may suggest a role for:

• Programming optimization
• Positional therapy
• Another adjunctive strategy

See Positional Sleep Apnea: Why Sleeping on Your Back Can Make OSA Worse.

How Do You Know if Inspire Is Working Well Enough?

Use multiple domains.

Objective Breathing Control

Consider:

• Treated AHI or REI
• Oxygenation
• Residual event type
• REM-related events
• Positional events

Symptoms

Consider:

• Sleepiness
• Snoring
• Morning headaches
• Sleep quality
• Functional improvement

Therapy Use

Ask:

• Is the patient activating therapy consistently?
• Is it being used throughout sleep?
• Is stimulation tolerable?

Long-Term Clinical Context

Consider:

• Weight change
• Cardiovascular conditions
• New symptoms
• Device issues

Successful treatment is not defined by:

“The implant is turned on.”

It is defined by:

adequate disease control with sustainable treatment use.

What if Inspire Only Partially Works?

Partial response is not necessarily treatment failure.

Suppose:

AHI 42 → AHI 14

That represents major improvement.

But residual OSA remains.

Possible next steps might include:

• Programming optimization
• Additional acclimation
• Positional therapy
• Weight management
• PAP in selected circumstances
• Oral appliance therapy or another combination strategy in selected patients
• Further airway evaluation

The correct response is:

measure the remaining problem → determine why it persists → address the residual disease.

The Effectiveness Principle

Do not judge HGNS by any single outcome.

Not:

“My snoring stopped.”

Not:

“I feel better.”

Not:

“My AHI dropped 50%.”

Not:

“I use the device every night.”

Instead ask:

How much OSA remains, what happens to oxygenation, are symptoms improving, is treatment used consistently, and is the therapy sustainable?

The best result combines:

strong physiologic response + consistent use + acceptable stimulation + improved symptoms + appropriate long-term follow-up.

What Happens During Inspire Surgery?

Hypoglossal nerve stimulation requires surgical implantation.

The procedure places the components needed to:

• Detect respiratory activity
• Deliver stimulation to selected hypoglossal nerve fibers
• Coordinate stimulation with breathing
• Power and control the implanted system

The precise surgical approach depends on the device, surgeon, patient anatomy, and current technique.

The important point is:

implantation is only the beginning of HGNS treatment.

The device still needs to heal, be activated, programmed, and evaluated for effectiveness.

Is Inspire Surgery an Outpatient Procedure?

Many patients undergo HGNS implantation without a prolonged hospital stay.

But the appropriate setting depends on:

• Patient health
• Surgical approach
• Anesthesia
• Comorbidities
• Perioperative course
• Treating facility

Patients should follow the surgical team’s specific instructions rather than assuming every implantation follows an identical pathway.

Is General Anesthesia Used?

Implantation is generally performed under anesthesia appropriate for the surgical procedure.

Because patients with OSA may have perioperative airway and respiratory considerations, the anesthesia team should know about:

• OSA severity
• PAP treatment
• Cardiopulmonary disease
• Other medical conditions
• Medications
• Previous anesthesia problems

For more about cardiovascular, cerebrovascular, perioperative, and accident risks associated with untreated OSA, see Untreated Sleep Apnea Risks: Heart Disease, Stroke, High Blood Pressure, Surgery, and Accidents.

Where Are the Incisions?

Incision location depends on the implanted system and surgical technique.

The procedure typically requires access to the region of the hypoglossal nerve and placement of the pulse generator and respiratory-sensing components.

Surgical techniques have evolved, so patients should not assume that an older diagram or video necessarily represents the current procedure they will receive.

Ask the surgeon:

• How many incisions are expected?
• Where will they be?
• Where will the generator sit?
• What scars should I expect?
• What activity restrictions will I have?

Can You Feel the Generator Under the Skin?

Often, yes.

The generator is implanted beneath the skin, generally in the upper chest region.

How noticeable it feels or looks depends partly on:

• Body habitus
• Implant location
• Healing
• Individual anatomy

A palpable generator does not by itself mean something is wrong.

New swelling, redness, drainage, significant pain, or other concerning postoperative changes deserve surgical review.

What Is Recovery Like After Inspire Surgery?

Recovery varies among patients.

Potential early postoperative symptoms can include:

• Incisional discomfort
• Swelling
• Bruising
• Neck discomfort
• Chest discomfort
• Temporary tongue-related symptoms
• Fatigue after surgery

The surgical team should provide individualized instructions regarding:

• Wound care
• Bathing
• Activity
• Driving
• Lifting
• Pain medication
• Follow-up
• When to seek urgent care

Can You Go Back to Work Immediately?

That depends on:

• Type of work
• Surgical recovery
• Pain
• Medication use
• Physical demands
• Surgeon instructions

A sedentary occupation and a job requiring heavy lifting may have very different return-to-work timelines.

Can You Exercise After Surgery?

Activity restrictions are typically part of postoperative care.

Patients may be asked to temporarily limit certain:

• Arm movements
• Lifting
• Strenuous exercise
• Other activities

The exact restrictions depend on the procedure and surgeon.

Follow the treating team’s instructions rather than a generic internet timetable.

Does Inspire Start Working Immediately After Surgery?

No—not in the way many patients expect.

The system is generally not immediately activated for therapeutic nightly stimulation on the day of implantation.

The surgical sites first need time to heal.

The sequence is more like:

implantation → healing → postoperative assessment → activation → acclimation → programming/optimization → objective assessment

This distinction is essential.

Why Isn’t Inspire Turned On Immediately?

Freshly operated tissues need time to recover.

Immediate therapeutic stimulation is generally not the objective during the early postoperative healing period.

Activation occurs later according to the treating program’s protocol and the patient’s recovery.

How Long Until Inspire Is Activated?

Activation commonly occurs after an initial healing period, but the exact timing should follow the implanting program’s protocol and individual recovery.

Avoid treating a particular number of weeks found online as a universal rule.

Factors may include:

• Wound healing
• Postoperative examination
• Surgical recovery
• Device-specific protocol
• Individual clinical circumstances

What Treats the Sleep Apnea While You Are Waiting for Activation?

The underlying OSA does not disappear simply because the device has been implanted.

The interim treatment plan should be discussed with the sleep and surgical teams.

Depending on the individual, this may involve continuation of an existing OSA strategy when clinically appropriate.

Do not independently assume:

“The implant is in, so I can stop CPAP tonight.”

What Happens at Inspire Activation?

At activation, the implanted system is evaluated and initial stimulation parameters are established.

The clinician may assess:

• Device function
• Stimulation response
• Tongue movement
• Sensation
• Tolerability
• Initial programming parameters

The patient also learns how to use the therapy controller.

What Does Stimulation Feel Like?

Sensation varies.

Patients may describe:

• Tongue movement
• Pulling
• Tingling
• Muscle activation
• Pressure-like sensation

The goal is not to make stimulation as strong as possible.

It should be:

therapeutically useful + tolerable enough to sleep with.

Is the First Setting the Final Setting?

Usually not.

Initial activation begins the therapeutic adjustment process.

The patient may need time to become accustomed to stimulation before settings are optimized.

Think:

activation ≠ completed titration.

Why Start at a Lower or More Comfortable Stimulation Level?

If stimulation is immediately uncomfortable, the patient may:

• Struggle to fall asleep
• Wake repeatedly
• Stop using therapy
• Develop poor tolerance

Gradual acclimation may allow treatment intensity to increase as appropriate while maintaining consistent use.

What Is Inspire Programming?

Programming determines how the implanted system delivers stimulation.

Clinicians can adjust therapy parameters according to:

• Upper-airway response
• Patient comfort
• Treatment effectiveness
• Device capabilities
• Clinical findings

The programming process is more sophisticated than simply:

“turn the voltage up.”

Is Voltage the Only Setting?

No.

Patients may hear discussion of stimulation strength, but HGNS programming involves more than one conceptual parameter.

Depending on the system, clinicians may consider aspects such as:

• Stimulation amplitude
• Electrode configuration
• Timing
• Pulse characteristics
• Respiratory synchronization
• Therapy delays

Patients do not need to independently optimize these technical parameters.

Can You Increase Inspire Yourself?

Patients may have limited control within parameters established by the treating team, depending on the device and programming.

That is different from independently reprogramming the implanted system.

Follow the prescribed acclimation plan.

Do not assume:

“If level 4 is good, level 10 must be better.”

Why Isn’t Stronger Stimulation Always Better?

Because treatment requires both:

airway response

and:

sleep tolerance.

Excessive stimulation could contribute to:

• Discomfort
• Awakenings
• Difficulty falling asleep
• Unpleasant tongue movement
• Reduced treatment use

And stronger stimulation does not necessarily produce proportional improvement in airway patency.

Can Stimulation Be Too Weak?

Yes.

If stimulation does not adequately improve upper-airway mechanics, clinically important residual OSA may remain.

That is why programming should ultimately be evaluated against actual treatment outcomes rather than sensation alone.

What Is the Inspire Remote Used For?

The patient controller or remote allows the user to manage routine therapy functions according to the system.

Depending on the device, functions may include:

• Turning therapy on
• Turning therapy off
• Pausing therapy
• Adjusting within permitted settings
• Other patient-accessible functions

The exact controls should be learned during activation.

What Is the Start Delay?

The start delay allows time to fall asleep before stimulation begins.

Conceptually:

turn on therapy → lie down → fall asleep → stimulation begins after the programmed delay

This can make treatment easier to tolerate.

What Is the Pause Feature?

If a patient wakes during the night, stimulation may feel distracting while awake.

A pause feature can temporarily stop stimulation and allow time to return to sleep before therapy resumes.

The exact function depends on the system.

Can You Pause Inspire Repeatedly During the Night?

The controller may permit pauses according to its programmed capabilities.

But frequent repeated pausing can reduce treatment exposure.

If stimulation repeatedly wakes the patient or requires frequent pauses, that deserves clinical review rather than simply accepting fragmented treatment.

How Long Does Inspire Acclimation Take?

There is substantial individual variation.

Some patients adapt relatively quickly.

Others require more time and programming adjustment.

The important goal is not to race through stimulation levels.

It is:

develop sustainable nightly use while moving toward effective treatment.

What if You Cannot Fall Asleep With Inspire?

Possible contributors include:

• Stimulation intensity
• Start-delay timing
• Anxiety or hyperawareness
• Insomnia
• Tongue discomfort
• Programming issues

Do not assume that every difficulty falling asleep means HGNS has failed.

The problem should be identified.

What if Inspire Wakes You Up?

Again, determine why.

Questions include:

• Is stimulation uncomfortable?
• Does it begin before the patient is asleep?
• Are awakenings caused by OSA itself?
• Is another sleep disorder present?
• Does programming need adjustment?

Simply lowering or raising stimulation without understanding the problem may not solve it.

How Is Inspire Titrated?

Historically, treatment optimization may involve clinical programming and objective sleep assessment.

The specific approach can vary by center and evolve as technology and treatment protocols change.

The goal is to identify settings that provide:

effective airway opening + acceptable comfort + sustainable use.

Does Everyone Need an Overnight Inspire Titration Study?

Not necessarily in exactly the same way.

Follow-up strategies may vary according to:

• Clinical program
• Device
• Symptoms
• Objective response
• Home testing capabilities
• Need for laboratory assessment
• Other clinical considerations

The important principle is that treatment effectiveness should be objectively evaluated, not that every patient must follow one identical testing pathway.

Should You Have a Follow-Up Sleep Study With Inspire?

Objective assessment is important because:

feeling stimulation does not prove that OSA is adequately controlled.

Depending on the clinical situation, follow-up may involve:

• Home sleep apnea testing
• Laboratory polysomnography
• Other validated clinician-directed assessment

See Home Sleep Apnea Test vs. Lab Sleep Study: Which One Do You Need?

What Should Follow-Up Testing Evaluate?

Important questions include:

• What is the treated AHI or REI?
• How does it compare with baseline?
• What happens to oxygen saturation?
• Are residual events obstructive?
• Are events concentrated during REM?
• Are events concentrated while supine?
• Was therapy active for the relevant sleep period?
• Are symptoms improving?

The goal is not simply:

“Did the number go down?”

It is:

“Is the remaining disease adequately controlled?”

What if Follow-Up AHI Is Below 5?

That may represent excellent objective control under the conditions of the study.

Still consider:

• Oxygenation
• Symptoms
• REM sleep
• Sleeping position
• Study quality
• Treatment usage

A single number should be interpreted within the complete clinical picture.

What if Follow-Up AHI Is 10?

Context matters.

For example:

Baseline AHI 45 → treated AHI 10

represents a major response.

But residual OSA remains.

The clinician may consider whether:

• Further programming is possible
• Residual events are positional
• Residual events are REM-related
• Another adjunctive treatment is appropriate

What if Follow-Up AHI Is Still 25?

That deserves reassessment.

Possible explanations include:

• Inadequate stimulation
• Suboptimal programming
• Unfavorable residual airway collapse
• Positional disease
• Weight change
• Incomplete treatment use
• Another sleep-related breathing problem

The response should not simply be:

“turn it up.”

Determine why clinically significant disease remains.

Can REM Sleep Affect Inspire Results?

Yes.

Suppose:

Treated non-REM AHI: 3

but:

Treated REM AHI: 18

An overall average may conceal residual REM-related obstruction.

The amount of REM sleep captured during follow-up testing matters.

For more about REM-predominant obstruction, see REM-Related Sleep Apnea: What Does REM AHI Mean?

Can Sleeping Position Affect Inspire Results?

Yes.

A patient may have:

Treated nonsupine AHI: 4

but:

Treated supine AHI: 17

That suggests residual positional vulnerability.

See Positional Sleep Apnea: Why Sleeping on Your Back Can Make OSA Worse.

Can Positional Therapy Be Added to Inspire?

Potentially.

If HGNS substantially improves OSA but residual events occur predominantly while supine, positional treatment may provide additional benefit in selected patients.

Combination therapy should be assessed for actual effectiveness.

Can Weight Management Be Combined With Inspire?

Yes.

These strategies target different contributors.

HGNS

Attempts to improve upper-airway neuromuscular stability during sleep.

Weight Management

May reduce obesity-related upper-airway and respiratory-mechanical burden.

See Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

Can PAP Still Be Used After Inspire Implantation?

Potentially, in selected circumstances.

Having an HGNS implant does not make PAP physically or conceptually forbidden.

If significant residual OSA remains, treatment options should be considered according to the patient’s actual disease.

The appropriate strategy may involve:

• Further HGNS optimization
• PAP
• Positional therapy
• Weight management
• Another adjunctive treatment

Does Needing Another Treatment Mean Inspire Failed?

Not necessarily.

OSA can have multiple contributors.

For example:

HGNS substantially improves generalized obstruction

while:

positional therapy addresses residual supine disease.

That can represent rational combination therapy rather than treatment failure.

What Happens After Therapy Is Optimized?

Long-term management still matters.

Patients should continue to monitor for:

• Return of snoring
• Witnessed apnea
• Daytime sleepiness
• Weight change
• Stimulation intolerance
• Device-related symptoms
• New medical conditions

An implant should not become:

“set it and forget it forever.”

When Should Inspire Be Reassessed?

Reassessment may be appropriate when:

• Symptoms return
• Snoring returns
• Witnessed apnea returns
• Body weight changes substantially
• Stimulation becomes uncomfortable
• Treatment use declines
• Device problems are suspected
• Medical circumstances change
• Objective efficacy is uncertain

The Activation and Programming Principle

The correct pathway is not:

surgery → turn on Inspire → treatment complete.

It is:

implant → heal → activate → acclimate → program → use consistently → objectively measure response → optimize when necessary → monitor long term.

The implant is the hardware.

Effective OSA control is the treatment goal.

What Are the Risks and Side Effects of Inspire for Sleep Apnea?

Hypoglossal nerve stimulation can provide substantial benefit for appropriately selected patients with obstructive sleep apnea.

But Inspire is an implanted surgical treatment, so its potential adverse effects differ from those of CPAP or an oral appliance.

Possible issues can be divided into several categories:

• Surgical and wound-related problems
• Pain or swelling
• Nerve- or tongue-related symptoms
• Stimulation discomfort
• Sleep disruption
• Device or lead problems
• Infection
• Long-term generator/battery management
• Device-specific imaging and procedural considerations

Most importantly:

expected postoperative discomfort is not the same thing as a surgical complication, and feeling stimulation is not automatically evidence of a device problem.

New, severe, persistent, or worsening symptoms deserve appropriate evaluation.

What Are the Risks of Inspire Surgery?

Any surgical procedure carries potential risks.

Depending on the procedure and individual patient, possible complications may include:

• Pain
• Bleeding
• Hematoma
• Swelling
• Infection
• Wound problems
• Scarring
• Nerve-related symptoms
• Anesthesia-related complications
• Device- or lead-related problems
• Need for additional procedures

The individual risk depends partly on:

• Medical history
• Medications
• Anticoagulant or antiplatelet therapy
• Cardiopulmonary disease
• Surgical anatomy
• Procedure
• Healing
• Other patient-specific factors

Is Pain Normal After Inspire Surgery?

Some postoperative discomfort is expected.

Patients may experience discomfort involving:

• Incision sites
• Neck
• Upper chest
• Surrounding muscles and tissues

Pain should generally follow the expected postoperative course described by the surgical team.

Severe, rapidly worsening, or otherwise concerning pain deserves evaluation.

Is Swelling Normal?

Some postoperative swelling can occur.

But swelling should be interpreted in context.

Contact the surgical team promptly for concerning findings such as:

• Rapidly increasing swelling
• Significant neck swelling
• Difficulty breathing
• Difficulty swallowing
• Significant bleeding
• Severe worsening pain
• Other symptoms specified in postoperative instructions

Difficulty breathing or rapidly progressive neck swelling requires urgent medical attention.

Can You Get a Hematoma?

Bleeding into the surgical tissues can occur after surgery.

A significant hematoma in the neck or chest can require urgent evaluation.

This is one reason patients should follow postoperative instructions regarding:

• Medications
• Activity
• Wound monitoring
• When to seek urgent care

Can the Inspire Implant Become Infected?

Yes.

Infection is a potential complication of any implanted medical device.

Possible warning signs may include:

• Increasing redness
• Warmth
• Swelling
• Drainage
• Fever
• Worsening incisional pain
• Wound breakdown

These symptoms should be reported promptly.

Why Is Device Infection Important?

An infection involving implanted hardware can be more complicated than a superficial skin infection.

Depending on the severity and location, treatment may require:

• Antibiotics
• Additional procedures
• Device revision
• Removal of implanted components in selected cases

Patients should not attempt to manage a suspected implant infection solely with home remedies.

Can Inspire Affect the Hypoglossal Nerve?

The stimulation lead interfaces with the hypoglossal nerve, and nerve-related symptoms can occur.

Potential symptoms may include:

• Tongue weakness
• Altered tongue movement
• Tongue discomfort
• Other changes in tongue function

Some postoperative symptoms may be temporary.

Persistent or significant abnormalities deserve evaluation.

What Does Tongue Weakness Look Like?

Possible manifestations can include:

• Difficulty moving the tongue normally
• Asymmetric tongue movement
• Difficulty manipulating food
• Speech changes
• Other functional symptoms

A patient’s treating surgeon should evaluate significant new tongue weakness rather than assuming it is simply normal stimulation.

Is Tongue Movement During Therapy Normal?

Yes.

The purpose of therapy is to activate selected hypoglossal motor pathways.

Therefore, visible or perceived tongue movement during stimulation can be expected.

The important distinction is between:

expected programmed tongue activation

and:

new persistent weakness or abnormal movement when therapy is not stimulating.

Can Inspire Make Your Tongue Sore?

Some patients may experience tongue-related discomfort associated with stimulation or contact with the teeth.

Potential issues may include:

• Tongue soreness
• Irritation
• Abrasion
• Discomfort from movement

If stimulation repeatedly causes the tongue to contact the teeth or produces significant discomfort, programming and oral factors may need review.

Can Inspire Affect Speech?

Temporary speech-related symptoms may occur in association with postoperative tongue or nerve effects.

Persistent or significant speech changes deserve evaluation.

During normal daytime life, the therapy is generally turned off, so routine speech should not involve continuous therapeutic stimulation.

Can Inspire Affect Swallowing?

Swallowing-related symptoms may occur after surgery or in association with nerve-related effects.

Persistent:

• Difficulty swallowing
• Choking
• Aspiration concerns
• Significant tongue weakness

should not simply be ignored.

The treating team should evaluate clinically important symptoms.

What Does Uncomfortable Stimulation Feel Like?

Patients may describe stimulation as:

• Strong tongue movement
• Pulling
• Tingling
• Muscle contraction
• Uncomfortable tongue displacement
• Another unusual localized sensation

Some sensation is expected.

The goal is not necessarily:

“I should feel nothing.”

The goal is:

stimulation that effectively improves airway patency while remaining tolerable enough for sustained sleep.

Can Stimulation Be Painful?

It should not simply be assumed that painful stimulation is necessary for effective treatment.

If therapy is painful or repeatedly awakens the patient, the HGNS team should review:

• Stimulation settings
• Electrode configuration
• Acclimation
• Timing
• Other possible causes

Do not independently keep increasing stimulation in response to inadequate sleep.

What if the Tongue Moves Too Far?

Excessive or uncomfortable movement may indicate that programming deserves review.

More visible movement does not necessarily mean better OSA control.

The therapeutic target is:

favorable airway opening

not:

maximum tongue excursion.

Can Inspire Cause Insomnia or Sleep Fragmentation?

Potentially.

A patient may have difficulty sleeping because of:

• Awareness of stimulation
• Stimulation discomfort
• Start timing
• Anxiety about the implant
• Repeated pauses
• Another sleep disorder
• Residual OSA

If sleep becomes fragmented, determine the cause rather than assuming the implant itself is fundamentally incompatible with sleep.

What if Stimulation Wakes You Repeatedly?

Repeated awakenings can reduce both sleep quality and treatment exposure.

Potential responses may involve:

• Programming review
• Acclimation changes
• Start-delay adjustment
• Evaluation for insomnia
• Evaluation for residual OSA
• Investigation of another sleep disorder

The correct response is not automatically:

“increase the stimulation.”

Can Inspire Stop Working?

A previously effective therapy can become less effective for several reasons.

Possible contributors include:

• Weight change
• Changes in OSA severity
• Programming needs
• Device or lead problems
• Changes in airway anatomy
• Inconsistent use
• Other medical changes

Return of snoring or sleepiness does not prove hardware failure.

It signals the need to determine what changed.

What Are Signs That Inspire May Need Reassessment?

Possible clues include:

• Return of loud snoring
• Recurrent witnessed apnea
• Increasing daytime sleepiness
• Morning headaches
• Reduced perceived stimulation
• New uncomfortable stimulation
• Difficulty activating therapy
• Unexpected changes in tongue movement
• New device-related symptoms
• Objective testing showing increased residual OSA

Can an Inspire Lead Move or Fail?

Implanted leads and other hardware can potentially develop mechanical problems.

These are not the most common explanation for every symptom change, but device integrity may need evaluation when clinically indicated.

The treatment team can assess:

• Device function
• Programming
• Stimulation response
• Other system information

What if You Suddenly Cannot Feel Stimulation?

Possible explanations range from simple to more significant.

Questions include:

• Is therapy actually activated?
• Is the controller functioning?
• Have settings changed?
• Is the device communicating normally?
• Is there a hardware or lead issue?

Contact the treating team rather than assuming the implant has failed.

What if Stimulation Suddenly Feels Very Different?

A major unexpected change deserves assessment.

Possible considerations include:

• Programming
• Device function
• Lead-related issues
• Changes in tissue response
• Other factors

Do not repeatedly alter patient-accessible settings in an attempt to diagnose an unexplained major change.

Can the Device Need Revision Surgery?

Yes, in selected circumstances.

Potential reasons for another procedure can include:

• Infection
• Hardware problems
• Lead problems
• Generator replacement
• Other device-related issues

The need for revision varies and should not be interpreted as an inevitable part of therapy.

Can Inspire Be Removed?

Implanted HGNS components can potentially require explantation in selected circumstances.

Reasons might include:

• Infection
• Device complications
• Intolerance
• Other clinical considerations

Removal is itself a surgical procedure and should be discussed with an experienced treating team.

Does the Inspire Battery Last Forever?

No.

The implanted pulse generator has a finite battery life.

Battery longevity depends on factors including:

• Device model
• Therapy settings
• Amount of stimulation
• Usage

Patients should expect long-term device management rather than assuming the original generator remains functional indefinitely.

What Happens When the Battery Runs Low?

The generator can require surgical replacement.

This is different from replacing an external household battery.

The implanted generator is a medical device component.

The treating team monitors the system and plans replacement when appropriate.

Does the Entire System Have to Be Replaced When the Battery Runs Out?

Not necessarily.

Generator replacement and replacement of other system components are different issues.

What needs to be replaced depends on:

• Device status
• Lead function
• Generator status
• Clinical circumstances
• Device-specific considerations

Do not assume every battery replacement means repeating the entire original implantation.

Can You Have an MRI With Inspire?

This requires device-specific verification.

Some HGNS systems and models may be MR Conditional, meaning MRI can be performed only under specified conditions.

Those conditions can depend on factors such as:

• Exact implanted model
• Components
• Body region being imaged
• MRI equipment
• Scanner parameters
• Other manufacturer-defined conditions

Therefore:

“I have Inspire” is not enough information to determine MRI safety.

What Should You Tell the MRI Facility?

Tell them that you have an implanted hypoglossal nerve stimulation system.

Provide the exact device information requested.

The imaging team may need to verify:

• Manufacturer
• Model
• Implant components
• MRI conditions
• Required device settings
• Other precautions

Never assume compatibility based on another patient’s implant.

Should You Keep Your Device Identification Information?

Yes.

Patients with implanted medical devices should keep appropriate device identification information available.

This can be important for:

• MRI
• Emergency care
• Surgery
• Other procedures
• Travel
• Device troubleshooting

What About CT Scans or X-Rays?

Different imaging technologies interact with implanted devices differently.

Routine X-rays and CT are not the same as MRI.

But questions about imaging or procedures should be addressed according to the specific implanted system and manufacturer guidance.

The safest approach is:

identify the exact device → tell the imaging team → verify current device-specific instructions.

Can You Go Through Airport Security With Inspire?

People with implanted medical devices routinely travel, but security procedures can vary.

Carry the appropriate device identification information and follow current manufacturer and transportation-security guidance.

If asked about an implant, tell security personnel that you have an implanted medical device.

Will Inspire Set Off a Metal Detector?

The interaction with security systems can depend on the equipment and implanted device.

Do not rely on whether another patient triggered an alarm.

Follow current device-manufacturer and security-agency guidance.

Can You Fly With Inspire?

The implant itself does not require transporting a PAP machine or humidifier.

However, patients should bring the controller/remote and any appropriate device information according to manufacturer instructions.

Travel planning should consider what happens if:

• The controller is lost
• The controller fails
• Medical care is needed away from home

What if You Lose the Inspire Remote?

Contact the treating program or appropriate device-support channel for replacement guidance.

Without the required controller, routine activation or management of therapy may be affected.

Do not assume a phone or another generic remote can substitute unless the specific system supports that function.

Can You Have Surgery After Inspire Is Implanted?

Yes, patients with implanted devices may later require unrelated surgery.

But the surgical and anesthesia teams should know about the implant.

Depending on the procedure, considerations may include:

• Electrocautery
• Imaging
• Device management
• Positioning
• Other implanted equipment

Device-specific perioperative guidance should be followed.

Should You Tell Every Doctor About Inspire?

It is particularly important to tell clinicians involved in:

• Surgery
• Anesthesia
• MRI
• Procedures involving electrical equipment
• Device-related evaluation
• Emergency care

The implant should be part of the medical history.

Can Inspire Interact With a Pacemaker or Other Implant?

Potential interactions depend on the exact devices.

Having another implanted electronic system does not automatically mean HGNS cannot be used.

But compatibility should be evaluated by the relevant specialists and according to current manufacturer guidance.

What if You Need CPR or Defibrillation?

Emergency lifesaving treatment should not be delayed because of an implanted HGNS system.

After certain emergency interventions, device evaluation may be appropriate according to the clinical circumstances and manufacturer guidance.

Patients should not attempt to manage an emergency around protecting the implant.

The medical emergency comes first.

When Should You Call the Surgeon?

Contact the surgical team for concerns such as:

• Worsening incision redness
• Drainage
• Fever associated with wound concerns
• Significant swelling
• Wound separation
• Severe postoperative pain
• New significant tongue weakness
• Significant swallowing problems
• Other postoperative concerns identified by the surgical team

Urgent symptoms such as difficulty breathing, rapidly progressive neck swelling, or another medical emergency require urgent evaluation.

When Should You Contact the Sleep/HGNS Team?

Contact the team managing therapy when:

• Stimulation becomes difficult to tolerate
• Therapy repeatedly wakes you
• You cannot activate treatment
• Stimulation suddenly changes
• Snoring or witnessed apnea returns
• Daytime sleepiness returns
• Weight changes substantially
• Objective testing suggests residual OSA
• Programming needs reassessment

What if You Feel Fine but Haven’t Had Objective Follow-Up?

Feeling better is valuable.

But:

symptom improvement does not establish complete OSA control.

This is especially important when baseline OSA was:

• Moderate or severe
• Associated with substantial desaturation
• Associated with important comorbidities

Appropriate objective assessment remains part of responsible treatment.

See Home Sleep Apnea Test vs. Lab Sleep Study: Which One Do You Need?

Five Device-Safety Habits

1. Know Exactly Which Device You Have

Keep the appropriate identification information.

2. Tell Relevant Clinicians About the Implant

Especially before MRI, surgery, or procedures.

3. Do Not Independently Chase Stronger Stimulation

More is not automatically better.

4. Report Significant New Surgical or Neurologic Symptoms

Do not assume every symptom is normal adaptation.

5. Maintain Long-Term Follow-Up

HGNS is an implanted long-term therapy.

The Safety Principle

Inspire introduces a different tradeoff from PAP or oral appliance therapy.

There is no mask or pressurized airflow.

But there is:

surgery + implanted hardware + electrical stimulation + programming + long-term device management.

The correct question is therefore not:

“Is Inspire safer than CPAP?”

It is:

“For this appropriately selected patient, do the expected benefits of HGNS justify the surgical and long-term device considerations compared with the reasonable alternatives?”

That decision is individualized.

Inspire vs. CPAP: Which Is Better for Sleep Apnea?

There is no universal winner.

CPAP and hypoglossal nerve stimulation treat obstructive sleep apnea through fundamentally different mechanisms.

CPAP

Uses positive airway pressure to pneumatically stabilize the upper airway during sleep.

Inspire/HGNS

Uses implanted electrical stimulation to activate selected upper-airway motor pathways during sleep.

If the question is:

Which treatment can most reliably eliminate obstructive respiratory events across a broad range of patients when used appropriately?

PAP remains an extremely effective treatment.

But treatment effectiveness also depends on whether the patient can actually use the therapy consistently.

For appropriately selected patients who cannot obtain sustainable treatment with PAP, HGNS may provide a valuable alternative.

See CPAP & PAP Therapy.

CPAP and Inspire are only two of several established approaches to OSA. For a broader side-by-side comparison of PAP, oral appliance therapy, positional therapy, weight management, Inspire/hypoglossal nerve stimulation, anatomic surgery, and combination treatment—and how OSA severity, anatomy, PAP tolerance, body weight, REM and positional patterns, and patient preference influence the choice—see Sleep Apnea Treatment Options: CPAP, Oral Appliances, Weight Loss, Inspire, Surgery, and More.

Is Inspire Better Than CPAP Because There Is No Mask?

Not necessarily.

Avoiding a mask eliminates several PAP-related problems, including:

• Mask leak
• Mask pressure
• Tubing
• PAP-related dry mouth from airflow or mouth leak
• Pressurized airflow sensation
• Some forms of PAP-related aerophagia

But HGNS introduces different considerations:

• Surgery
• Implanted hardware
• Stimulation
• Programming
• Device maintenance
• Generator replacement
• Device-specific imaging considerations

The absence of a mask does not make HGNS automatically easier or safer for every patient.

Is Inspire More Comfortable Than CPAP?

For some patients, yes.

For others, stimulation may initially feel unusual or interfere with sleep.

Comfort depends on:

• Stimulation settings
• Acclimation
• Sleep quality
• Individual sensation
• Treatment response

The correct comparison is not:

mask versus no mask

but:

effective sustainable PAP versus effective sustainable HGNS.

Inspire vs. Oral Appliance Therapy

Both treatments can provide non-PAP treatment for selected patients with OSA.

But they differ substantially.

Oral Appliance

• Removable
• Non-surgical
• Mechanically advances/stabilizes the mandible
• Requires dental suitability
• Can produce dental and bite changes
• Requires objective verification of OSA control

HGNS

• Surgically implanted
• Electrically activates upper-airway motor pathways
• Requires anatomic and physiologic candidacy
• Requires activation and programming
• Requires long-term implanted-device management
• Requires objective verification of treatment response

See Oral Appliance Therapy for Sleep Apnea: How It Works, Who Qualifies, and Does It Work?

Should You Try an Oral Appliance Before Inspire?

Sometimes that may be reasonable.

But there is no universal rule requiring every patient to progress through an identical sequence.

Consider:

• OSA severity
• Dental suitability
• PAP experience
• Upper-airway anatomy
• Expected treatment response
• Patient preference
• Coverage requirements

A removable non-surgical therapy may be attractive when it is clinically appropriate.

But an oral appliance should not be used merely as an administrative step if it is unlikely to provide adequate treatment.

Inspire vs. Positional Therapy

Positional therapy is fundamentally less invasive.

It attempts to reduce sleep in positions—usually supine sleep—in which OSA is substantially worse.

For someone with strongly positional disease, the sleep study might show:

Supine AHI: 38

Nonsupine AHI: 4

That creates a different treatment discussion from:

Supine AHI: 38

Nonsupine AHI: 29

In the first patient, positional treatment may have considerable potential.

In the second, substantial OSA persists regardless of position.

See Positional Sleep Apnea: Why Sleeping on Your Back Can Make OSA Worse.

Can Inspire and Positional Therapy Be Combined?

Yes, in selected patients.

Suppose optimized HGNS produces:

Nonsupine AHI: 3

but:

Supine AHI: 14

If avoiding back sleeping further reduces residual obstruction, combination treatment may be useful.

This is not necessarily evidence that HGNS failed.

It may mean the patient has more than one important contributor to airway collapse. For a detailed guide to treating residual positional OSA—including side sleeping, positional devices, vibrotactile therapy, head-of-bed elevation, adherence, and objective follow-up testing—see Positional Therapy for Sleep Apnea: Does Sleeping on Your Side Really Work?

Inspire vs. Weight Management

These therapies address different components of OSA.

HGNS

Improves upper-airway neuromuscular function during sleep.

Weight Management

May reduce obesity-related contributors to upper-airway collapse and respiratory mechanics.

For patients with obesity, these strategies can be complementary.

See Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

Should You Lose Weight Instead of Getting Inspire?

That is not a universal either/or decision.

Weight management may be medically important regardless of whether HGNS is used.

But substantial weight reduction:

• Takes time
• Varies in magnitude
• Does not guarantee OSA remission
• May or may not provide sufficient immediate control of clinically significant OSA

The patient still needs an appropriate strategy for existing OSA.

Can GLP-1–Based Weight Treatment Replace Inspire?

Not automatically.

Modern obesity pharmacotherapy can produce substantial weight loss in appropriately selected patients.

Weight reduction may significantly improve obesity-related OSA.

But:

weight-loss medication ≠ guaranteed elimination of OSA

and:

HGNS ≠ treatment for obesity.

They address different disease components.

What About Bariatric Surgery?

Metabolic/bariatric surgery can produce major and sustained weight reduction in appropriately selected patients.

OSA may improve substantially.

But residual OSA can persist.

The treatment decision should therefore consider:

• Obesity severity
• OSA severity
• Metabolic health
• Surgical candidacy
• Airway anatomy
• Patient goals

Inspire vs. Other Sleep Apnea Surgery

HGNS itself is a surgical treatment, but it is not the only surgical approach to OSA.

Other procedures may target:

• Tonsils
• Soft palate
• Tongue base
• Nasal structures
• Craniofacial anatomy
• Maxillomandibular position
• Other sites of obstruction

Different procedures address different anatomic problems. For a comprehensive guide to anatomic surgical treatment—including tonsillectomy, UPPP and other palatal procedures, tongue-base surgery, genioglossus advancement, maxillomandibular advancement (MMA), nasal surgery, multilevel surgery, success rates, risks, recovery, and postoperative testing—see Sleep Apnea Surgery: Types, Who Qualifies, Success Rates, Risks, and Alternatives.

Is Inspire Better Than UPPP?

Not universally.

Uvulopalatopharyngoplasty (UPPP) targets tissues in the palatal/oropharyngeal region.

HGNS primarily uses neuromuscular stimulation to influence upper-airway patency.

The appropriate treatment depends partly on:

where and how the airway collapses.

What About Maxillomandibular Advancement?

Maxillomandibular advancement, or MMA, is a craniofacial surgical procedure that advances the upper and lower jaws.

It can substantially enlarge the upper airway in appropriately selected patients.

But it is a very different intervention from HGNS in:

• Mechanism
• Surgical magnitude
• Recovery
• Anatomy addressed
• Risk profile

Treatment should be selected according to the patient’s actual anatomy and clinical circumstances.

Comparing Major OSA Treatments

Treatment	How It Works	Major Strength	Important Limitation
CPAP/APAP	Pneumatically stabilizes the upper airway	Usually highly effective while used	Requires consistent use; mask, leak, pressure, and comfort issues may occur
Oral appliance	Advances/stabilizes the mandible and upper airway	Non-surgical, portable, often well tolerated	Response varies; dental/jaw effects require monitoring
Positional therapy	Reduces sleep in positions associated with greater obstruction	Noninvasive and useful for selected positional OSA	May not control non-positional disease
Weight management	Reduces obesity-related contributors to OSA	Treats an important underlying disease driver	Does not guarantee OSA remission
HGNS/Inspire	Stimulates upper-airway motor pathways during sleep	Avoids PAP mask and can substantially improve OSA in selected patients	Requires surgery, specific candidacy, programming, and long-term device management
Other upper-airway surgery	Modifies anatomic structures contributing to obstruction	Can directly address important structural abnormalities	Procedure, efficacy, recovery, and risks vary
Combination therapy	Uses more than one strategy	Can address multiple contributors simultaneously	Requires individualized coordination and objective assessment

These treatments are not necessarily competitors. OSA is often multifactorial, and some patients may appropriately use more than one treatment over time or simultaneously.

Can You Still Use CPAP After Getting Inspire?

Potentially.

An HGNS implant does not make PAP inherently unusable.

If clinically important residual OSA persists, treatment options should be based on the actual problem.

For selected patients, that could include PAP.

The objective is:

adequate OSA control

rather than loyalty to one treatment modality.

Can Inspire and an Oral Appliance Be Used Together?

Potentially in selected circumstances, although this is not a routine requirement.

Because the treatments affect upper-airway mechanics differently, combination strategies may occasionally be considered when one treatment alone leaves residual disease.

But:

two treatments ≠ automatically better treatment.

The combination should have a clear clinical rationale and its effectiveness should be assessed.

Can Inspire and Weight Loss Work Together?

Absolutely.

If obesity contributes to OSA, treating obesity remains medically important even after successful HGNS implantation.

Likewise, weight loss should not automatically lead to turning off HGNS without reassessment.

What if Inspire Only Partially Controls OSA?

Do not immediately classify treatment as either:

success

or:

failure.

Instead ask:

1. Is therapy being used consistently?
2. Is stimulation tolerable?
3. Can programming be optimized?
4. Are residual events positional?
5. Are residual events REM-related?
6. Has body weight changed?
7. Is another type of sleep-disordered breathing present?
8. Would combination therapy help?

That approach identifies the remaining problem.

What if Inspire Does Not Work Well Enough?

Options may include:

• Programming optimization
• Additional objective assessment
• Positional therapy
• Weight management
• PAP
• Oral appliance therapy in selected patients
• Additional airway evaluation
• Another surgical strategy in appropriate circumstances

An implanted device should not prevent clinicians from reconsidering the treatment plan.

Can Inspire Be Turned Off Permanently if OSA Improves?

The device can be turned off, but the clinical question is whether treatment is still needed.

Suppose a patient loses substantial weight and no longer snores.

That does not prove OSA has resolved.

Appropriate reassessment should determine whether clinically significant disease remains.

What if You Gain Significant Weight After Inspire?

Reassessment may be appropriate.

Substantial weight gain may:

• Worsen underlying OSA
• Increase residual disease
• Alter treatment response
• Affect long-term management

Do not simply increase stimulation indefinitely without determining why OSA control has changed.

Does Inspire Mean You Never Need Another Sleep Study?

No.

Objective reassessment may be useful when:

• Treatment efficacy needs confirmation
• Programming is being optimized
• Symptoms return
• Body weight changes substantially
• Residual OSA is suspected
• Other clinical circumstances change

See Home Sleep Apnea Test vs. Lab Sleep Study: Which One Do You Need?

Ten Questions to Ask Before Inspire Surgery

1. Why Am I a Candidate for HGNS?

Ask which features of your OSA and airway make the treatment appropriate.

2. What Does My Sleep Study Actually Show?

Know:

• AHI
• Obstructive events
• Central/mixed events
• Oxygenation
• Positional pattern
• REM-related severity

3. Why Has PAP Not Provided Sustainable Treatment?

Make sure correctable PAP problems have been considered.

4. What Did My DISE Show?

Ask specifically about:

• Palatal collapse
• Tongue-base collapse
• Lateral-wall collapse
• Epiglottic involvement
• Complete concentric collapse

5. How Does My Body Weight Affect My Expected Response?

Separate:

device eligibility

from:

probability of optimal response.

6. What Are the Surgical Risks in My Case?

Discuss:

• Bleeding
• Infection
• Nerve-related symptoms
• Wound complications
• Anesthesia
• Device complications
• Potential revision

7. When Will the Device Be Activated?

Understand:

surgery → healing → activation → acclimation

rather than expecting treatment immediately after implantation.

8. How Will We Know Whether It Works?

There should be a plan for:

• Programming
• Symptom review
• Objective assessment

9. What Happens if I Have Residual OSA?

Discuss combination and alternative strategies before surgery rather than assuming the implant must solve everything.

10. What Does Long-Term Device Management Involve?

Ask about:

• Follow-up
• Programming
• Generator/battery management
• MRI
• Other procedures
• Travel
• Device identification
• Revision/replacement

Five Mistakes to Avoid With Inspire

Mistake 1: Assuming CPAP Intolerance Automatically Means You Qualify

HGNS candidacy requires much more than disliking a PAP mask.

Mistake 2: Using an Old BMI or AHI Cutoff From the Internet as a Universal Rule

Device labeling and payer requirements can differ and evolve.

Verify current criteria.

Mistake 3: Thinking Surgery Completes the Treatment

Implantation is followed by:

healing → activation → acclimation → programming → objective assessment.

Mistake 4: Assuming Stronger Stimulation Is Always Better

The goal is effective, tolerable airway activation—not maximum tongue movement.

Mistake 5: Assuming Less Snoring Means OSA Is Cured

Snoring can improve while residual obstructive events remain.

When Should You Seek Reassessment?

Consider reassessment if:

• Snoring returns
• Witnessed apnea returns
• Daytime sleepiness develops or worsens
• Stimulation becomes uncomfortable
• Therapy repeatedly disrupts sleep
• You have difficulty activating therapy
• Tongue movement changes unexpectedly
• Body weight changes substantially
• Device problems are suspected
• Follow-up testing shows clinically important residual OSA

A Better Way to Think About Inspire

Instead of asking:

“How do I get Inspire instead of CPAP?”

ask:

1. What Is My OSA Phenotype?

Consider:

• Severity
• Event type
• Oxygenation
• REM
• Position

2. Why Has PAP Not Worked for Me?

Determine whether the problem is correctable.

3. What Does My Airway Anatomy Show?

This includes dynamic collapse during DISE when appropriate.

4. What Other Treatments Are Reasonable?

Consider:

• PAP optimization
• Oral appliance therapy
• Positional therapy
• Weight management
• HGNS
• Other surgery
• Combination treatment

5. How Will We Verify Success?

A treatment plan should include an objective endpoint.

The Bottom Line

Inspire for sleep apnea is an implanted hypoglossal nerve stimulation treatment for appropriately selected patients with obstructive sleep apnea.

It works fundamentally differently from CPAP.

Instead of pneumatically splinting the airway with pressurized air, HGNS:

senses breathing → stimulates selected hypoglossal motor pathways → activates upper-airway muscles → helps maintain airway patency during sleep

For the right patient, HGNS can produce substantial improvements in:

• AHI
• Oxygen-related measures
• Snoring
• Daytime sleepiness
• Sleep-related quality of life

But:

implantation does not guarantee cure.

Successful treatment depends heavily on patient selection.

Candidacy involves much more than:

AHI + BMI + CPAP intolerance.

It may require consideration of:

• Predominantly obstructive disease
• Central and mixed event burden
• OSA severity
• PAP history
• Body habitus
• Upper-airway anatomy
• DISE findings
• Complete concentric palatal collapse
• Medical and surgical considerations
• Current device labeling
• Current payer requirements

Importantly:

FDA/device labeling ≠ clinical candidacy ≠ Medicare coverage ≠ commercial insurance coverage.

Those frameworks overlap but should not be treated as identical.

After implantation, treatment is not complete.

The pathway continues:

heal → activate → acclimate → program → use consistently → objectively assess response → optimize → monitor long term

Some patients achieve excellent control.

Others experience substantial improvement with residual OSA.

Others may respond inadequately.

When residual disease remains, the correct response is not automatically:

“turn the stimulation higher.”

Instead evaluate:

programming + treatment use + REM + sleeping position + body weight + airway anatomy + residual respiratory-event type

and consider adjunctive therapy when appropriate.

HGNS also introduces considerations that do not exist with a removable treatment:

• Surgery
• Implanted hardware
• Stimulation
• Generator/battery management
• Device-specific MRI requirements
• Potential revision procedures
• Long-term follow-up

That does not make it inferior to PAP or oral appliance therapy.

It makes it different.

The most useful question is therefore not:

“Is Inspire better than CPAP?”

It is:

“Given my type and severity of OSA, airway anatomy, PAP experience, medical circumstances, and treatment preferences, is hypoglossal nerve stimulation an appropriate option—and how will we objectively determine whether it adequately controls my sleep apnea?”

That is the question that turns Inspire from an appealing device into a properly selected and monitored treatment for obstructive sleep apnea.

References & Further Reading

1. Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-Airway Stimulation for Obstructive Sleep Apnea. New England Journal of Medicine. 2014;370:139–149.
   https://doi.org/10.1056/NEJMoa1308659
2. Woodson BT, Strohl KP, Soose RJ, et al. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Otolaryngology–Head and Neck Surgery. 2018;159(1):194–202.
   https://doi.org/10.1177/0194599818762383
3. Heiser C, Steffen A, Boon M, et al. Post-approval Upper Airway Stimulation Predictors of Treatment Effectiveness in the ADHERE Registry. European Respiratory Journal. 2019;53(1):1801405.
   https://doi.org/10.1183/13993003.01405-2018
4. Vanderveken OM, Maurer JT, Hohenhorst W, et al. Evaluation of Drug-Induced Sleep Endoscopy as a Patient Selection Tool for Implanted Upper Airway Stimulation for Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine. 2013;9(5):433–438.
   https://doi.org/10.5664/jcsm.2658
5. Kent DT, Carden KA, Wang L, et al. Evaluation of Hypoglossal Nerve Stimulation Treatment in Obstructive Sleep Apnea. JAMA Otolaryngology–Head & Neck Surgery. 2019;145(11):1044–1052.
   https://doi.org/10.1001/jamaoto.2019.2723
6. U.S. Food and Drug Administration. Inspire Upper Airway Stimulation System — Premarket Approval and supplemental approval information.
   https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130008
7. Inspire Medical Systems. Indications & Contraindications. Current manufacturer information for Inspire Upper Airway Stimulation therapy.
   https://professionals.inspiresleep.com/en-us/indications-and-contraindications/
8. Inspire Medical Systems. MRI Guidelines for Inspire Therapy. Device-specific MRI information and conditions.
   https://manuals.inspiresleep.com/
9. Centers for Medicare & Medicaid Services. Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea — applicable Medicare coverage policies should be verified according to the patient’s jurisdiction and current coverage requirements.
   https://www.cms.gov/medicare-coverage-database/
10. American Academy of Sleep Medicine. Clinical Practice Guideline for Referral of Adults With Obstructive Sleep Apnea for Surgical Consultation. Journal of Clinical Sleep Medicine. 2021;17(12):2499–2505.
    https://doi.org/10.5664/jcsm.9592

Medical Author & Reviewer
Kwaku Osafo-Mensah, MD
Pulmonary Medicine | Sleep Medicine
Diplomate, American Board of Sleep Medicine (ABSM)
More than 20 years of experience in sleep medicine

Medically reviewed: September 2026.
About the medical reviewer · Editorial Policy

Medical Disclaimer: This article is provided for general educational purposes and is not a substitute for individualized medical, surgical, sleep-medicine, or insurance-coverage evaluation. Hypoglossal nerve stimulation is an implanted treatment for appropriately selected patients with obstructive sleep apnea. Whether it is appropriate for a particular patient depends on factors including the type and severity of sleep apnea, respiratory-event composition, PAP treatment history, upper-airway anatomy, drug-induced sleep endoscopy findings when applicable, body habitus, medical conditions, surgical considerations, and other individualized factors.

Device indications, contraindications, age and disease-severity ranges, body-mass-index considerations, MRI conditions, and other manufacturer or regulatory requirements can change. Medicare and commercial insurers may also apply coverage criteria that differ from device labeling or clinical candidacy. FDA/device labeling, clinical candidacy, Medicare coverage, and commercial-insurance coverage should not be assumed to be identical. Current criteria should be verified with the treating team, current manufacturer/FDA information, and the patient’s insurer when relevant.

Implantation does not establish that obstructive sleep apnea has been adequately treated. HGNS generally requires postoperative healing, activation, acclimation, programming, consistent use, and appropriate follow-up assessment. Improvement in snoring, symptoms, or perceived stimulation does not by itself prove that OSA is adequately controlled. Objective reassessment may be appropriate to evaluate residual respiratory events and oxygenation.

Patients with an implanted HGNS system should inform relevant healthcare professionals before MRI, surgery, procedures involving electrical equipment, or other situations in which an implanted device may affect management. MRI eligibility and scanning conditions are device- and model-specific and should be verified using current manufacturer guidance. New difficulty breathing, rapidly progressive neck swelling, significant bleeding, severe swallowing difficulty, signs of surgical-site infection, or another medical emergency requires prompt medical evaluation.